Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Interictal and Ictal MEG in presurgical evaluation for epilepsy surgery (2020) Stefan H, Rampp S Journal article, Review article Challenging a Preconception: Optoacoustic Spectrum Differs from the Optical Absorption Spectrum of Proteins and Dyes for Molecular Imaging (2020) Werner JPF, Huang Y, Mishra K, Janowski R, Vetschera P, Heichler C, Chmyrov A, et al. Journal article Sodium Handling and Interaction in Numerous Organs (2020) Minegishi S, Luft FC, Titze J, Kitada K Journal article The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism (2020) Wild M, Hahn F, Grau B, Herrmann L, Niesar A, Schütz M, Lorion MM, et al. Journal article Low dose radiation therapy, particularly with 0.5 gy, improves pain in degenerative joint disease of the fingers: Results of a retrospective analysis (2020) Donaubauer AJ, Zhou J, Ott OJ, Putz F, Fietkau R, Keilholz L, Gaipl U, et al. Journal article Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials (2020) Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, et al. Journal article Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine (2020) Lampert A, Bennett DL, McDermott LA, Neureiter A, Eberhardt E, Winner B, Zenke M Journal article CRISPR/Cas9 mediated generation of human ARID1B heterozygous knockout hESC lines to model Coffin-Siris syndrome (2020) Börstler T, Wend H, Krumbiegel M, Kavyanifar A, Wiesmann da Silva Reis A, Lie DC, Winner B, Turan S Journal article, Original article Comprehensive profile of platelet derived growth factor receptor alpha (PDGFRA) mutations in gastrointestinal stromal tumors (2020) Khosroyani H, Klug LR, Town A, Lategahn J, Falkenhorst J, Grunewald S, Muhlenberg T, et al. Conference contribution Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30) (2020) Multhoff G, Combs SE, Seier S, Stangl S, Sievert W, Shevtsov M, Blankenstein C, et al. Conference contribution